Login / Signup

Is administration of proton pump inhibitors in functional dyspepsia worth the risk of developing gastric cancer: a Markov model to bridge the gap between scientific evidence and clinical practice.

Efrat BroideAdi Eindor-AbarbanelHaim ShirinVered RichterShay MatalonMoshe Leshno
Published in: BMJ open (2020)
To bridge the gap between evidence and decision making, we found that even a small improvement in the QALY justified continuing PPI treatment.
Keyphrases
  • decision making
  • clinical practice
  • helicobacter pylori infection
  • combination therapy
  • protein protein
  • helicobacter pylori
  • replacement therapy
  • irritable bowel syndrome